CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis
NASDAQ:CCRN - Nasdaq - US2274831047 - Common Stock - Currency: USD
CCRN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, there are worries on its profitability. CCRN is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
In the past year CCRN had a positive cash flow from operations.
In multiple years CCRN reported negative net income over the last 5 years.
Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -3.08%, CCRN perfoms like the industry average, outperforming 40.20% of the companies in the same industry.
With a Return On Equity value of -4.24%, CCRN perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.08% | ||
| ROE | -4.24% | ||
| ROIC | N/A |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of CCRN has declined.
With a Gross Margin value of 20.32%, CCRN perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
In the last couple of years the Gross Margin of CCRN has declined.
The Profit Margin and Operating Margin are not available for CCRN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.32% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
CCRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CCRN has less shares outstanding than it did 1 year ago.
CCRN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CCRN has an Altman-Z score of 4.77. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.77, CCRN belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.77 |
ROIC/WACCN/A
WACC9.05%
2.3 Liquidity
CCRN has a Current Ratio of 2.98. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
CCRN has a better Current ratio (2.98) than 87.25% of its industry peers.
CCRN has a Quick Ratio of 2.98. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
CCRN has a better Quick ratio (2.98) than 87.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.98 |
3. Growth
3.1 Past
The earnings per share for CCRN have decreased strongly by -79.49% in the last year.
CCRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.57% yearly.
CCRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.16%.
Measured over the past years, CCRN shows a quite strong growth in Revenue. The Revenue has been growing by 10.33% on average per year.
EPS 1Y (TTM)-79.49%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-68.42%
Revenue 1Y (TTM)-29.16%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-22.62%
3.2 Future
CCRN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.79% yearly.
The Revenue is expected to decrease by -0.05% on average over the next years.
EPS Next Y-18.4%
EPS Next 2Y9.26%
EPS Next 3Y10.79%
EPS Next 5YN/A
Revenue Next Year-10.1%
Revenue Next 2Y-2.67%
Revenue Next 3Y-0.05%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 41.28, which means the current valuation is very expensive for CCRN.
Compared to the rest of the industry, the Price/Earnings ratio of CCRN is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.25. CCRN is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 24.59, CCRN is valued on the expensive side.
CCRN's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.15. CCRN is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.28 | ||
| Fwd PE | 24.59 |
4.2 Price Multiples
CCRN's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CCRN is valued cheaply inside the industry as 96.08% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.89 | ||
| EV/EBITDA | 27.39 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.68
EPS Next 2Y9.26%
EPS Next 3Y10.79%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CCRN (6/2/2025, 12:12:50 PM)
13.21
+0.03 (+0.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.1%
Inst Owner Change5.81%
Ins Owners5.71%
Ins Owner Change0.18%
Market Cap433.02M
Analysts52.31
Price Target18.98 (43.68%)
Short Float %8.27%
Short Ratio6.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-30.26%
Min EPS beat(2)-66.11%
Max EPS beat(2)5.59%
EPS beat(4)2
Avg EPS beat(4)-16.07%
Min EPS beat(4)-66.11%
Max EPS beat(4)22.23%
EPS beat(8)5
Avg EPS beat(8)-5.82%
EPS beat(12)9
Avg EPS beat(12)-0.39%
EPS beat(16)13
Avg EPS beat(16)7.65%
Revenue beat(2)0
Avg Revenue beat(2)-3.28%
Min Revenue beat(2)-5.84%
Max Revenue beat(2)-0.73%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-5.84%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.29%
Revenue beat(16)8
Avg Revenue beat(16)1.65%
PT rev (1m)0%
PT rev (3m)6.6%
EPS NQ rev (1m)-29.04%
EPS NQ rev (3m)-45.59%
EPS NY rev (1m)-4.91%
EPS NY rev (3m)-37%
Revenue NQ rev (1m)-2.96%
Revenue NQ rev (3m)-3.02%
Revenue NY rev (1m)-2.92%
Revenue NY rev (3m)-3.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.28 | ||
| Fwd PE | 24.59 | ||
| P/S | 0.34 | ||
| P/FCF | 3.89 | ||
| P/OCF | 3.61 | ||
| P/B | 1.04 | ||
| P/tB | 1.78 | ||
| EV/EBITDA | 27.39 |
EPS(TTM)0.32
EY2.42%
EPS(NY)0.54
Fwd EY4.07%
FCF(TTM)3.4
FCFY25.73%
OCF(TTM)3.65
OCFY27.66%
SpS38.38
BVpS12.76
TBVpS7.42
PEG (NY)N/A
PEG (5Y)1.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.08% | ||
| ROE | -4.24% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.32% | ||
| FCFM | 8.85% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score4
Asset Turnover2.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.77% | ||
| Cap/Sales | 0.67% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 933.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.98 | ||
| Altman-Z | 4.77 |
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.49%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-68.42%
EPS Next Y-18.4%
EPS Next 2Y9.26%
EPS Next 3Y10.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.16%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-22.62%
Revenue Next Year-10.1%
Revenue Next 2Y-2.67%
Revenue Next 3Y-0.05%
Revenue Next 5YN/A
EBIT growth 1Y-106.89%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year706.57%
EBIT Next 3Y126.18%
EBIT Next 5YN/A
FCF growth 1Y-44.19%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-42.96%
OCF growth 3YN/A
OCF growth 5Y85.29%